New England Journal of Medicine · 1990 · 362 citations · 42 references
MedicineGeneticsHematologyHematopathologyHuman GeneticsImmunogeneticsAnemiaComplement DisordersComplement SystemHemolytic DisordersRed Blood Cell DisordersSickle Cell DiseaseC3 CleavageC3 ConvertaseComplement Activation PathwaysComplement Component DeficiencyComplement In Hematologic DisordersComplement System AbnormalitiesDecay-accelerating FactorErythrocyte Membrane Glycoproteins
PAROXYSMAL nocturnal hemoglobinuria is a rare acquired disease caused by an unusual susceptibility of erythrocytes to the lytic action of complement. The abnormal erythrocytes are thought to originate from the clonal proliferation of bone marrow progenitors altered by somatic mutation.1 Erythrocytes from patients with paroxysmal nocturnal hemoglobinuria have been shown to be deficient in membrane glycoproteins, such as decay-accelerating factor (DAF)2 , 3 and a factor called either homologous restriction factor4 (HRF) or C8-binding protein5 (C8bp). DAF can inhibit the formation and induce the dissociation of C3 convertases of the classical and alternative pathways of complement activation.6 7 8 HRF/C8bp appears to limit the . . .
42
Alun Davies, David L. Simmons, G Hale et al. · The Journal of Experimental Medicine · 1989 · 641 citations · Full text
M. Edward Medof, Taroh Kinoshita, Victor Nussenzweig · The Journal of Experimental Medicine · 1984 · 563 citations · Full text
A Nicholson-Weller, JP March, S I Rosenfeld et al. · Proceedings of the National Academy of Sciences · 1983 · 434 citations · Full text
Medicine, Hematology, Immunology +17